Diabetes, Digestive, and Kidney Diseases Extramural Research in South Carolina
Diabetes, Digestive, and Kidney Diseases Extramural Research (93.847) awarded $82.9 million to recipients in South Carolina in 68 grants from fiscal 2021 to 2025, 0.9% of the program's national total. The Medical University of South Carolina received the most, $34.9 million.
- Awarded in South Carolina$82.9 million
- Awards68
- Share of the program0.9%
- Rank among states25th of 51
- National total$9.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 27 | $12.3 million |
| FY 2022 | 35 | $15.2 million |
| FY 2023 | 42 | $19.0 million |
| FY 2024 | 39 | $18.3 million |
| FY 2025 | 33 | $18.0 million |
Recipients in South Carolina
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The Medical University of South Carolina | Colleges and universities | 32 | $34.9 million |
| University of South Carolina | Colleges and universities | 22 | $34.6 million |
| Sylvatica Biotech Inc | Small businesses | 2 | $3.9 million |
| Expanse Bio LLC | Small businesses | 1 | $2.4 million |
| Clemson University | Colleges and universities | 2 | $2.2 million |
| Zylo Therapeutics, Inc. | Small businesses | 2 | $2.0 million |
| Adva-Tec Inc | Small businesses | 1 | $879,019 |
| Furman University | Colleges and universities | 1 | $416,456 |
| Tissue Testing Technologies LLC | Small businesses | 1 | $385,522 |
| Lydex Pharmaceuticals LLC | Small businesses | 1 | $349,905 |
Open opportunities under this program
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Diabetes Research Centers (P30 Clinical Trial Optional)
- Silvio O. Conte Digestive Diseases Research Core Centers (P30-Clinical Trial Optional)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 64 on the program page
Questions people ask
How much Diabetes, Digestive, and Kidney Diseases Extramural Research money goes to South Carolina?
$82.9 million from fiscal 2021 to 2025, across 68 awards. South Carolina ranks 25th of 51 states and territories for this program.
Who receives Diabetes, Digestive, and Kidney Diseases Extramural Research money in South Carolina?
The largest recipient is The Medical University of South Carolina, with $34.9 million in 32 awards. Next are University of South Carolina and Sylvatica Biotech Inc.
Can organizations in South Carolina apply now?
Yes, 64 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Diabetes, Digestive, and Kidney Diseases Extramural Research in other states
Other large programs in South Carolina
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Child Care and Development Block Grant
- Title I Grants to Local Educational Agencies
- Special Education Grants to States
- Children's Health Insurance Program
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Head Start